放射性诱导的化脓性汗腺炎：一例报告。 - Suppr

Suppr

超能文献

Radiation-induced hidradenitis suppurativa: A case report.

作者信息

Haber Roger, Gottlieb Jeremy, Zagdanski Anne-Marie, Battistella Maxime, Bachelez Herve

机构信息

Department of Dermatology, Saint Georges Hospital University Medical Center, Beirut, Lebanon.

Service de Dermatologie, Hôpital Saint-Louis, Paris, France.

出版信息

JAAD Case Rep. 2017 Apr 14;3(3):182-184. doi: 10.1016/j.jdcr.2017.02.013. eCollection 2017 May.

DOI:10.1016/j.jdcr.2017.02.013

PMID:28443304

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5394191/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e05/5394191/51193ca221cc/gr1.jpg

相似文献

Radiation-induced hidradenitis suppurativa: A case report.放射性诱导的化脓性汗腺炎：一例报告。

JAAD Case Rep. 2017 Apr 14;3(3):182-184. doi: 10.1016/j.jdcr.2017.02.013. eCollection 2017 May.

HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.化脓性汗腺炎临床反应（HiSCR）：一种用于评估阿达木单抗2期研究安慰剂对照部分中化脓性汗腺炎患者治疗效果的新型临床终点。

J Eur Acad Dermatol Venereol. 2016 Jun;30(6):989-94. doi: 10.1111/jdv.13216. Epub 2015 Jul 22.

Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.一项2期随机双盲研究安慰剂对照部分中阿达木单抗治疗中重度化脓性汗腺炎女性患者的研究

J Drugs Dermatol. 2016 Oct 1;15(10):1192-1196.

Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa.阿达木单抗诱发反常性化脓性汗腺炎的观察性病例系列

J Dermatolog Treat. 2016;27(3):251-3. doi: 10.3109/09546634.2015.1094179. Epub 2015 Oct 20.

Effects of adalimumab on T-helper-17 lymphocyte- and neutrophil-related inflammatory serum markers in patients with moderate-to-severe hidradenitis suppurativa.阿达木单抗对中重度化脓性汗腺炎患者 Th17 淋巴细胞和中性粒细胞相关炎症血清标志物的影响。

Cytokine. 2018 Mar;103:20-24. doi: 10.1016/j.cyto.2017.12.020. Epub 2017 Dec 28.

Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa.阿达木单抗治疗日本中重度化脓性汗腺炎患者的 3 期开放标签试验 24 周中期分析。

J Dermatol. 2019 Sep;46(9):745-751. doi: 10.1111/1346-8138.14997. Epub 2019 Jul 8.

Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa.阿达木单抗治疗活动性中度至重度化脓性汗腺炎的研究聚焦

Clin Cosmet Investig Dermatol. 2016 Oct 19;9:367-372. doi: 10.2147/CCID.S93619. eCollection 2016.

Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease.阿达木单抗用于治疗化脓性汗腺炎的临床经验。与克罗恩病的缓解率比较。

Actas Dermosifiliogr. 2016 Sep;107 Suppl 2:43-50. doi: 10.1016/S0001-7310(17)30008-X.

Clinical response rate and flares of hidradenitis suppurativa in the treatment with adalimumab.阿达木单抗治疗化脓性汗腺炎的临床应答率和病情恶化。

Clin Exp Dermatol. 2020 Jun;45(4):438-444. doi: 10.1111/ced.14127. Epub 2019 Dec 24.

Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.基于欧洲化脓性汗腺炎指南的化脓性汗腺炎/反向性痤疮循证治疗方法

Rev Endocr Metab Disord. 2016 Sep;17(3):343-351. doi: 10.1007/s11154-016-9328-5.

引用本文的文献

Delivery of high-dose radiation for recurrence of breast cancer in a patient with hidradenitis suppurativa.为患有化脓性汗腺炎的乳腺癌复发患者提供大剂量放疗。

BMJ Case Rep. 2020 Nov 30;13(11):e238848. doi: 10.1136/bcr-2020-238848.

Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice.化脓性汗腺炎的医学和手术治疗：国际治疗指南综述及在普通皮肤科实践中的应用。

Dermatology. 2020;236(5):393-412. doi: 10.1159/000507323. Epub 2020 May 14.

T helper (Th)17 radiation-induced hidradenitis suppurativa.辅助性T细胞17型辐射诱发的化脓性汗腺炎

JAAD Case Rep. 2018 Apr 30;4(5):442. doi: 10.1016/j.jdcr.2017.12.005. eCollection 2018 Jun.

Radiation-induced inflammatory dermatosis: Another facet of the immunocompromised cutaneous district.辐射诱导的炎性皮肤病：免疫功能低下皮肤区域的另一个方面。

JAAD Case Rep. 2017 Nov 10;3(6):572-573. doi: 10.1016/j.jdcr.2017.06.034. eCollection 2017 Nov.

Hidradenitis suppurativa after radiotherapy for uterine adenocarcinoma: A typical example of an isoradiotopic response.子宫腺癌放疗后发生化脓性汗腺炎：放射性同位反应的一个典型例子。

JAAD Case Rep. 2017 Nov 10;3(6):570-571. doi: 10.1016/j.jdcr.2017.05.010. eCollection 2017 Nov.

本文引用的文献

Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa.阿达木单抗治疗化脓性汗腺炎的两项 3 期临床试验。

N Engl J Med. 2016 Aug 4;375(5):422-34. doi: 10.1056/NEJMoa1504370.

A case of radiation-induced localized exacerbation of hidradenitis suppurativa.一例放射性诱发的化脓性汗腺炎局部加重病例。

JAAD Case Rep. 2016 Jan 29;2(1):44-6. doi: 10.1016/j.jdcr.2015.11.009. eCollection 2016 Jan.

Inflammatory Mechanisms in Hidradenitis Suppurativa.化脓性汗腺炎的炎症机制

Dermatol Clin. 2016 Jan;34(1):51-8. doi: 10.1016/j.det.2015.08.004.

Pathophysiology of hidradenitis suppurativa: An update.化脓性汗腺炎的病理生理学：更新。

J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S8-11. doi: 10.1016/j.jaad.2015.07.045.

Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response.补体是放疗诱导的肿瘤特异性免疫和临床反应的核心介质。

Immunity. 2015 Apr 21;42(4):767-77. doi: 10.1016/j.immuni.2015.03.009. Epub 2015 Apr 14.

Hidradenitis suppurativa: the role of deficient cutaneous innate immunity.化脓性汗腺炎：皮肤先天性免疫缺陷的作用。

Arch Dermatol. 2012 Feb;148(2):182-6. doi: 10.1001/archdermatol.2011.315. Epub 2011 Oct 17.

The role of radiotherapy in the treatment of hidradenitis suppurativa: case report and review of the literature.放射治疗在化脓性汗腺炎治疗中的作用：病例报告及文献综述

Dermatol Online J. 2010 Feb 15;16(2):16.

Hidradenitis suppurativa.化脓性汗腺炎

J Eur Acad Dermatol Venereol. 2009 Sep;23(9):985-98. doi: 10.1111/j.1468-3083.2009.03356.x.

Altered innate and adaptive immune responses in patients with hidradenitis suppurativa.化脓性汗腺炎患者先天性和适应性免疫反应的改变。

Br J Dermatol. 2007 Jan;156(1):51-6. doi: 10.1111/j.1365-2133.2006.07556.x.

Ionizing radiation therapy in dermatology.皮肤科中的电离辐射疗法。

J Am Acad Dermatol. 1994 Feb;30(2 Pt 1):157-82; quiz 183-6. doi: 10.1016/s0190-9622(94)70014-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验